The expression and underlying angiogenesis effect of DPC4 and VEGF on the progression of cervical carcinoma

A,Yanni; Li,Ying; Zhao,Shuping

doi:10.3892/ol.2017.7580

The expression and underlying angiogenesis effect of DPC4 and VEGF on the progression of cervical carcinoma

Authors:
- Yanni A
- Ying Li
- Shuping Zhao
View Affiliations

Affiliations: Department of Gynecology, Qingdao Women and Children Hospital, Qingdao, Shandong 266000, P.R. China, Department of Pathology, Qingdao Municipal Hospital (Group), Qingdao, Shandong 266000, P.R. China, Department of Gynecology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266000, P.R. China
Published online on: December 11, 2017 https://doi.org/10.3892/ol.2017.7580
Pages: 2534-2540

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the expression and roles of deleted in pancreatic carcinoma locus 4 (DPC4) and vascular endothelial growth factor (VEGF) in the development of cervical carcinoma. A total of 115 patients aged between 25 and 60 years were involved, including 19 cervical inflammation, 35 cervical intraepithelial neoplasia (CIN), and 61 cervical squamous‑cell carcinoma (CSCC). The protein expression rates of DPC4 and VEGF in all samples were detected using immunohistochemistry. The protein levels of DPC4 and VEGF in CSCC samples were measured using ELISA. Microvessel density (MVD) of each CSCC sample was measured according to the Winder method. Association analysis between DPC4, VEGF and thrombospondin‑1 (TSP‑1) was conducted using Spearman's correlations. The negative expression rate of DPC4 [DPC4 (‑)] and positive expression rate of VEGF [VEGF (+)] of the CSCC group were significantly higher compared with that in the cervical inflammation and CIN groups (P<0.05). In the CSCC group, the protein level of DPC4 decreased, while the VEGF level increased significantly compared with the healthy control group (P<0.05). The MVD in the DPC4 (‑), VEGF (+) and TSP‑1 (‑) groups was significantly increased compared with that of the DPC4 (+), VEGF (‑), and TSP‑1 (+) groups (P<0.05). The expression of DPC4 was negatively associated with VEGF and TSP‑1 (P<0.01). These results suggest that DPC4, VEGF and TSP‑1 are involved in the carcinogenesis of cervical carcinoma by inducing angiogenesis. In addition, the loss of DPC4 induces angiogenesis through increasing VEGF. Thus, VEGF may be a target gene regulated by DPC4.

View Figures

View References

1	Arbyn M, Castellsagué X, de Sanjosé S, Bruni L, Saraiya M, Bray F and Ferlay J: Worldwide burden of cervical cancer in 2008. Ann Oncol. 22:2675–2686. 2011. View Article : Google Scholar : PubMed/NCBI
2	Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: GLOBOCAN 2008 v2.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]. International Agency for Research on Cancer, Lyon. 2010.29;2010. http://globocan.iarc.fr/Default.aspxJuly 12–2012
3	Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
4	Schwarte-Waldhoff I, Volpert OV, Bouck NP, Sipos B, Hahn SA, Klein-Scory S, Lüttges J, Klöppel G, Graeven U, Eilert-Micus C, et al: Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis. Proc Natl Acad Sci USA. 97:pp. 9624–9629. 2000; View Article : Google Scholar : PubMed/NCBI
5	Zhao S, Venkatasubbarao K, Lazor JW, Sperry J, Jin C, Cao L and Freeman JW: Inhibition of STAT3 Tyr705 phosphorylation by Smad4 suppresses transforming growth factor beta-mediated invasion and metastasis in pancreatic cancer cells. Cancer Res. 68:4221–4228. 2008. View Article : Google Scholar : PubMed/NCBI
6	Lee S, Cho YS, Shim C, Kim J, Choi J, Oh S, Kim J, Zhang W and Lee J: Aberrant expression of Smad4 results in resistance against the growth-inhibitory effect of transforming growth factor-beta in the SiHa human cervical carcinoma cell line. Int J Cancer. 94:500–507. 2001. View Article : Google Scholar : PubMed/NCBI
7	Carmeliet P: Mechanisms of angiogenesis and arteriogenesis. Nat Med. 6:389–395. 2000. View Article : Google Scholar : PubMed/NCBI
8	Smith-McCune K, Zhu YH, Hanahan D and Arbeit J: Cross-species comparison of angiogenesis during the premalignant stages of squamous carcinogenesis in the human cervix and K14-HPV16 transgenic mice. Cancer Res. 57:1294–1300. 1997.PubMed/NCBI
9	Veikkola T, Karkkainen M, Claesson-Welsh L and Alitalo K: Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res. 60:203–212. 2000.PubMed/NCBI
10	Dai Y, Zhang X, Peng Y and Wang Z: The expression of cyclooxygenase-2, VEGF and PGs in CIN and cervical carcinoma. Gynecol Oncol. 97:96–103. 2005. View Article : Google Scholar : PubMed/NCBI
11	Kodama J, Hashimoto I, Seki N, Hongo A, Yoshinouchi M, Okuda H and Kudo T: Thrombospondin-1 and-2 Messenger RNA Expression in Invasive Cervical Cancer: Correlation with Angiogenesis and Prognosis. Clin Cancer Res. 7:2826–2831. 2001.PubMed/NCBI
12	Ren B, Yee KO, Lawler J and Khosravi-Far R: Regulation of tumor angiogenesis by thrombospondin-1. Biochim Biophys Acta. 1765:178–188. 2006.PubMed/NCBI
13	Chen C, Sun MZ, Liu S, Yeh D, Yu L, Song Y, Gong L, Hao L, Hu J and Shao S: Smad4 mediates malignant behaviors of human ovarian carcinoma cell through the effect on expressions of E-cadherin, plasminogen activator inhibitor-1 and VEGF. BMB Rep. 43:554–560. 2010. View Article : Google Scholar : PubMed/NCBI
14	Lewin SN, Herzog TJ, Medel NI Barrena, Deutsch I, Burke WM, Sun X and Wright JD: Comparative performance of the 2009 international Federation of gynecology and obstetrics' staging system for uterine corpus cancer. Obstet Gynecol. 116:1141–1149. 2010. View Article : Google Scholar : PubMed/NCBI
15	Broders AC: Squamous cell epithelioma of the skin: A study of 256 cases. Ann Surg. 73:141–160. 1921. View Article : Google Scholar : PubMed/NCBI
16	Weidner N, Semple JP, Welch WR and Folkman J: Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med. 324:1–8. 1991. View Article : Google Scholar : PubMed/NCBI
17	Baldus SE, Schwarz E, Lohrey C, Zapatka M, Landsberg S, Hahn SA, Schmidt D, Dienes HP, Schmiegel WH and Schwarte-Waldhoff I: Smad4 deficiency in cervical carcinoma cells. Oncogene. 24:810–819. 2005. View Article : Google Scholar : PubMed/NCBI
18	Van Trappen PO, Steele D, Lowe DG, Baithun S, Beasley N, Thiele W, Weich H, Krishnan J, Shepherd JH, Pepper MS, et al: Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesis. J Pathol. 201:544–554. 2003. View Article : Google Scholar : PubMed/NCBI
19	Miyaki M, Iijima T, Konishi M, Sakai K, Ishii A, Yasuno M, Hishima T, Koike M, Shitara N, Iwama T, et al: Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Oncogene. 18:3098–3103. 1999. View Article : Google Scholar : PubMed/NCBI
20	Kloth JN, Kenter GG, Spijker HS, Uljee S, Corver WE, Jordanova ES, Fleuren GJ and Gorter A: Expression of Smad2 and Smad4 in cervical cancer: Absent nuclear Smad4 expression correlates with poor survival. Mod Pathol. 21:866–875. 2008. View Article : Google Scholar : PubMed/NCBI
21	Hahn SA, Bartsch D, Schroers A, Galehdari H, Becker M, Ramaswamy A, Schwarte-Waldhoff I, Maschek H and Schmiegel W: Mutations of the DPC4/Smad4 gene in biliary tract carcinoma. Cancer Res. 58:1124–1126. 1998.PubMed/NCBI
22	Bartsch D, Hahn SA, Danichevski KD, Ramaswamy A, Bastian D, Galehdari H, Barth P, Schmiegel W, Simon B and Rothmund M: Mutations of the DPC4/Smad4 gene in neuroendocrine pancreatic tumors. Oncogene. 18:2367–2371. 1999. View Article : Google Scholar : PubMed/NCBI
23	Elliott RL and Blobe GC: Role of transforming growth factor Beta in human cancer. J Clin Oncol. 23:2078–2093. 2005. View Article : Google Scholar : PubMed/NCBI
24	Miyazono K, Suzuki H and Imamura T: Regulation of TGF-beta signaling and its roles in progression of tumors. Cancer Sci. 94:230–234. 2003. View Article : Google Scholar : PubMed/NCBI
25	Schwarte-Waldhoff I and Schmiegel W: Smad4 transcriptional pathways and angiogenesis. Int J Gastrointest Cancer. 31:47–59. 2002. View Article : Google Scholar : PubMed/NCBI
26	Ke Z, Zhang X, Ma L and Wang L: Expression of DPC4/Smad4 in non-small-cell lung carcinoma and its relationship with angiogenesis. Neoplasma. 55:323–329. 2008.PubMed/NCBI
27	Kim MH, Seo SS, Song YS, Kang DH, Park IA, Kang SB and Lee HP: Expression of cyclooxygenase-1 and-2 associated with expression of VEGF in primary cervical cancer and at metastatic lymph nodes. Gynecol Oncol. 90:83–90. 2003. View Article : Google Scholar : PubMed/NCBI
28	Hasturk S, Kemp B, Kalapurakal SK, Kurie JM, Hong WK and Lee JS: Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma. Cancer. 94:1023–1031. 2002. View Article : Google Scholar : PubMed/NCBI
29	Tokunaga T, Oshika Y, Abe Y, Ozeki Y, Sadahiro S, Kijima H, Tsuchida T, Yamazaki H, Ueyama Y, Tamaoki N and Nakamura M: Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer. Br J Cancer. 77:998–1002. 1998. View Article : Google Scholar : PubMed/NCBI
30	Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, Sawada T and Sowa M: Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer. 77:858–863. 1996. View Article : Google Scholar : PubMed/NCBI
31	Dameron KM, Volpert OV, Tainsky MA and Bouck N: Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science. 265:1582–1584. 1994. View Article : Google Scholar : PubMed/NCBI
32	Jin RJ, Kwak C, Lee SG, Lee CH, Soo CG, Park MS, Lee E and Lee SE: The application of an anti-angiogenic gene (thrombospondin-1) in the treatment of human prostate cancer xenografts. Cancer Gene Ther. 7:1537–1542. 2000. View Article : Google Scholar : PubMed/NCBI
33	Li X, Liu B, Xiao J, Yuan Y, Ma J and Zhang Y: Roles of VEGF-C and Smad4 in the lymphangiogenesis, lymphatic metastasis, and prognosis in colon cancer. J Gastrointest Surg. 15:2001–2010. 2011. View Article : Google Scholar : PubMed/NCBI
34	Alvarez AA, Axelrod JR, Whitaker RS, Isner PD, Bentley RC, Dodge RK and Rodriguez GC: Thrombospondin-1 expression in epithelial ovarian carcinoma: Association with p53 status, tumor angiogenesis, and survival in platinum-treated patients. Gynecol Oncol. 82:273–278. 2001. View Article : Google Scholar : PubMed/NCBI
35	Grossfeld GD, Ginsberg DA, Stein JP, Bochner BH, Esrig D, Groshen S, Dunn M, Nichols PW, Taylor CR, Skinner DG and Cote RJ: Thrombospondin-1 expression in bladder cancer: Association with p53 alterations, tumor angiogenesis, and tumor progression. J Natl Cancer Inst. 89:219–227. 1997. View Article : Google Scholar : PubMed/NCBI
36	Grant SW, Kyshtoobayeva AS, Kurosaki T, Jakowatz J and Fruehauf JP: Mutant p53 correlates with reduced expression of thrombospondin-1, increased angiogenesis, and metastatic progression in melanoma. Cancer Detect Prev. 22:185–194. 1998. View Article : Google Scholar : PubMed/NCBI
37	Tokunaga T, Nakamura M, Oshika Y, Tsuchida T, Kazuno M, Fukushima Y, Kawai K, Abe Y, Kijima H, Yamazaki H, et al: Alterations in tumour suppressor gene p53 correlate with inhibition of thrombospondin-1 gene expression in colon cancer cells. Virchows Arch. 433:415–418. 1998. View Article : Google Scholar : PubMed/NCBI